The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I may be incorrect but am considering the buy back as indication that the business is going well and is making money. They would look very stupid if the next quarter showed the buy back was ‘unaffordable’.
Paul
Nalunaq is only a fraction of the total area. You are correct that total across the whole area is expected to be in excess of 1.5m ounces
I subscribe to Regency Research who are pretty switched on and more importantly, independent. On Friday, they put out a long term buy notice and research note on Tremor. Was well written and thought out. Sorry can’t share but it did make me buy some more on Friday.
I subscribe to Regency Research who are pretty switched on and more importantly, independent. On Friday, they put out a long term buy notice and research note on Tremor. Was well written and thought out. Sorry can’t share but it did make me buy some more on Friday.
Bodes not boxes !
I agree with that Bristolian. This is not a typical grab and run AIM stock. They are clearly setting up for long term growth. I used to work with one of the board members. He was one of the smartest of his generation and a very decent guy with it which always boxes well.
Sign up for Betaville Qwertyii. It's £3,500 per quarter. No ? I didn't think so
At the risk of being called a ramper, it's not the first time I've heard that rumour. I like the stock with or without rumour so I remain indifferent on any rumours. That said, I wouldn't be unhappy with a bid...obviously !!
Goldenyears. It would be good to know more about Ingenuity clients. For me, a little bit more patience is needed on that one. From what I hear it is doing well but the numbers will reveal all. However, I think it is not valued correctly in the share price. By how much I don’t yet know and I suspect we will find out soon enough
Frankly, I'm glad this fundraise is announced and over. It has been the reason the price won't break out. It's not a big discount to current price either. I will be buying on any weakness.
Agreed Sharcus...there's nothing wrong with shareholder activism. There are 605 members on the 4D Telegram group.
I suggest we wait for the 12th April and see what it looks like. However, the financial press is not interested in the well being of PIs trying to make money (even if in support of a cancer solution) but they are interested in 'fat cats' making a fortune by shorting companies that have made announcements like the recent one.
Name and shame is the game (sorry !)
Hi Sharcus
We will find out on next reporting date on 12th April. I have diarised it. I will do everything in my power to make sure this is picked up by the FT if any specific funds have significant shorts.
It will be interesting to see if the FT pick up the story as I think it is morally reprehensible to be massively shorting a company that has come up with a potential solution for terminal cancer sufferers. To be clear, I am not against shorting in general but this is taking the wotsit. And as interesting will be how any funds that are short chose to react.